Is innovation becoming a lost art in the pharmaceutical industry? A new survey of 282 pharmaceutical executives, done at the behest of clinical research organization Quintiles, found that 54 percent consider innovation to be a leading priority and 49 percent rank their overall innovation strategy as, at best, moderately effective, says Pharmalot's Ed Silverman.